Evidence map›Paper›PMID 39161754›Full record

ArticleJournal of the American College of Emergency Physicians open2024

Heroin or fentanyl: Prevalence of confirmed fentanyl in ED patients with suspected heroin overdose.

Siri Shastry, Jonathan Lin, Kim Aldy, Jeffrey Brent, Paul Wax, Alex Krotulski, Sharan Campleman, Shao Li, Alison Meyn, Stephanie Abston and 11 more

Abstract read
In one paragraph

Article in Journal of the American College of Emergency Physicians open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. The nitazene epidemic in Estonia: a first report.European journal of public health · 2025
    Article
  5. Article
  6. Heroin or fentanyl: Prevalence of confirmed fentanyl in ED patients with suspected heroin overdose.Journal of the American College of Emergency Physicians open · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Siri ShastryIcahn School of Medicine at Mount Sinai New York New York USA.
Jonathan LinIcahn School of Medicine at Mount Sinai New York New York USA.ORCID https://orcid.org/0000-0002-7484-2521
Kim AldyAmerican College of Medical Toxicology Phoenix Arizona USA.
Jeffrey BrentUniversity of Colorado School of Medicine Aurora Colorado USA.
Paul WaxAmerican College of Medical Toxicology Phoenix Arizona USA.
Alex KrotulskiCenter for Forensic Science Research and Education, Fredric Rieders Family Foundation Willow Grove Pennsylvania USA.
Sharan CamplemanAmerican College of Medical Toxicology Phoenix Arizona USA.
Shao LiAmerican College of Medical Toxicology Phoenix Arizona USA.
Alison MeynAmerican College of Medical Toxicology Phoenix Arizona USA.
Stephanie AbstonAmerican College of Medical Toxicology Phoenix Arizona USA.
Barry LoganCenter for Forensic Science Research and Education, Fredric Rieders Family Foundation Willow Grove Pennsylvania USA.
Alexandra AmaducciLehigh Valley Health Network/USF Morsani College of Medicine Allentown Pennsylvania USA.
Bryan JudgeCorewell Health Michigan State University Grand Rapids Michigan USA.
Michael LevineUniversity of California-Los Angeles Los Angeles California USA.
Diane CalelloRutgers New Jersey Medical School Newark New Jersey USA.
Joshua ShulmanUniversity of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA.
Adrienne HughesOregon Health and Science University Portland Oregon USA.
Rachel CulbrethAmerican College of Medical Toxicology Phoenix Arizona USA.
Evan SchwarzWashington University School of Medicine St Louis Missouri USA.
Alex F ManiniIcahn School of Medicine at Mount Sinai Center for Research on Emerging Substances Poisoning, Overdose, and New Discoveries (RESPOND) NYC Health + Hospitals/Elmhurst New York New York USA.
Toxicology Investigators Consortium Fentalog Study Group

Funding

Predicting medical consequences of novel fentanyl analog overdose using the Toxicology Investigators Consortium (TOXIC) R01DA048009 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Alex Francis Manini · 2020 to 2026
$6.7M
NIDA NIH HHS R01 DA048009
6 · The paper itself

Abstract

Background: United States drug overdose deaths are being driven by the increasing prevalence of fentanyl, but whether patients are knowingly using fentanyl is unclear. We examined the analytical confirmation of fentanyl in emergency department (ED) patients with documented heroin overdose. Hypothesis: We hypothesized that the proportion of fentanyl and fentanyl analogs would be higher than that of confirmed heroin. Methods: This is a subgroup analysis from a prospective multicenter consecutive cohort of ED patients age 18+ with opioid overdose presenting to 10 US sites within the Toxicology Investigators Consortium from 2020 to 2021. Toxicology analysis was performed using liquid chromatography quadrupole time-of-flight mass spectrometry. De-identified toxicology results were paired with the clinical database. The primary outcome was the proportion of patients with fentanyl analytes detected in their serum. Results: Of 1006 patients screened, 406 were eligible, and of 168 patients who reported that they had taken heroin or had a documented heroin overdose, 88% ( Conclusion: The prevalence of confirmed fentanyl in ED patients with suspected heroin overdose was extremely high, while the prevalence of heroin was very low. There was a high degree of mismatch between the opioids believed to be the overdose agent versus the actual opioids identified on serum toxicology. Clinicians in the United States should presume that fentanyl is involved in all illicit opioid overdoses and should counsel patients on harm reduction measures.

Indexed as

fentanylheroinopioidsoverdose

Identifiers

PMID39161754
PMCPMC11331419

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.